Testing effectiveness (Phase 2)Ended earlyNCT05998447
What this trial is testing
GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
Who this might be right for
Biliary Tract Cancer
Genome & Company 10
Showing 20 of 0 results